ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 303861 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 303861; 2) Community: the network communities that were significantly associated with the response to NSC 303861; 3) Molecule: the relationships between components within communities and NSC 303861; 4) MDR: the compounds that were significantly associated with the NSC 303861.

NSC Compound Enrichment Correlation
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0385613993886001 0.44204267
NSC 719715 Null 0.0385613993886001 0.29337434
NSC 720447 Null 0.0385613993886001 -0.34163646
NSC 721049 7Z-Plakortide H 0.0385613993886001 0.25833837
NSC 723548 Null 0.0385613993886001 0.55272246
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0385613993886001 0.4113161
NSC 740 Methotrexate 0.0385613993886001 0.52834706
NSC 743530 Null 0.0385613993886001 0.51020882
NSC 744063 Null 0.0385613993886001 0.38696588
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0385613993886001 0.30273977
Total:80  Current:66    [First] [Prev] [Next] [Last]